For Drug, Diagnostic and Device Developers
Cambridge Biomedical professionals are experts in providing bioanalytical services from preclinical through phase IV clinical trials. We have a proven track record of success in complex, custom biomarker and assay development, optimization, validation, and sample testing. We provide a diverse range of simple to highly complex, routine to esoteric assays; and we can accommodate study sizes with low, medium, or high volume sample testing requirements. Since 1997, Cambridge Biomedical has validated and placed into commercial diagnostic use over 150 assays across a wide variety of disorders.